7-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-1-oxo-

Catalog No. :
ACIPET168
CAS No. :
1343932-64-8
Molecular Formula :
C10H9NO3
Molecular Weight :
191.19

IUPAC Name:1-oxo-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid

7-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-1-oxo- structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$54.00Login to see priceIn stockInquiry
250mg95%$65.00Login to see priceIn stockInquiry
1g95%$259.00Login to see priceIn stockInquiry
5g95%$1050.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-1-oxo-
IUPAC Name1-oxo-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid
MDL No.MFCD19683459
Molecular FormulaC10H9NO3
Molecular Weight191.19
SMILESO=C(C1=CC2=C(C=C1)CCNC2=O)O
InChI KeyHAXKBOAGHSGHLU-UHFFFAOYSA-N
Synonym7-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-1-oxo-;1-oxo-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid;3,4-Dihydro-2H-isoquinolin-1-one-7-carboxylic acid;1,2,3,4-Tetrahydro-1-oxo-7-isoquinolinecarboxylic acid
CAS No.1343932-64-8
PubChem CID64224049

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIPET168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSWIU986 route compound structure diagram
    ACSWIU9861245798-40-6 In Stock
  2. Then
  3. ACIPET168 route product structure diagram
    ACIPET1681343932-64-8 In Stock
Inquiry

2. ACIPET168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIPET168 route product structure diagram
    ACIPET1681343932-64-8 In Stock
Inquiry

Comments (0)